Siemens officials question whether they should keep the company's majority stake in its former medtech division, Siemens ...

Autonomix received a patent from the U.S. Patent and Trademark Office (USPTO) for its catheter-based cancer tumor treating ...

[Image from Unsplash] In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through acquisitions. Over the course of the year, the ...

Olympus has engaged a global executive recruitment firm to assist a board search committee evaluating CEO candidates.

CMS announced a proposed decision to cover transcatheter tricuspid valve replacement (TTVR) for Medicare beneficiaries.

Over the past 12 months, a number of medtech companies at various stages hauled in significant funding rounds to support ...

BD (NYSE: BDX) + continues to grapple with problems related to technology it brought over from its $12 billion acquisition of CareFusion nearly a decade ago. Our Drug Delivery Business News sibling ...

Roivios announced that it received FDA investigational device exemption (IDE) approval to conduct a trial for its renal ...

With approval, the company can begin commercializing the device in the U.S. in 2025.